1Y Close · As of Aug 26, 2026
KOMIPHARM INTERNATIONAL operates in the Pharmaceuticals sector.
Legal name: KOMIPHARM INTERNATIONAL CO., LTD.
In fiscal year 2025, KOMIPHARM INTERNATIONAL (041960) reported revenue of 52.5 billion KRW, down 10.7% from 58.8 billion KRW a year earlier.
Operating profit was 2.0 billion KRW and net income was -8.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 687.1 billion KRW, with a P/B of 9.54.
These figures can be verified in the DART filing (receipt no. 20260318001653).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 52.5B | 2.0B | -8.0B |
| 2024 | 58.8B | 6.2B | 14.7B |
| 2023 | 42.6B | -6.3B | -5.9B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-13 | Semi-Annual Report (2026.06) |